- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT00211835
Treatment of Post-TBI Depression
Treatment of Post-TBI Depression - A Randomized Clinical Trial
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Goals Demonstrate the efficacy of cognitive behavioral therapy (CBT), both immediately after treatment and in the long term, in alleviating post-TBI depression.
Examine the relationship between improved mood, participation, and life satisfaction.
Implement exploratory analyses of the relationships between person and injury characteristics and outcomes of treatment.
Maximize potential application to clinical practice by:
Implementing the treatment in a clinical context so that its utility is demonstrated in a setting that maximizes ecological validity, and Creating and disseminating a manual detailing CBT treatment. This study is a randomized clinical trial that compares two treatment conditions: CBT and supportive psychotherapy (SPT). CBT has been shown to be effective in diverse studies. In this study, CBT has been shaped to be used specifically with people with typical post-TBI cognitive challenges. All participants will be given an opportunity to immediately receive a randomly assigned psychotherapy intervention to potentially enhance coping. Both CBT and SPT will involve 16 sessions of individual treatment. The initial session will be 90 minutes, with remaining sessions 50 minutes. In both treatments, participants will be seen for three months, with sessions twice weekly for the first month and once a week subsequently. The research assistants who will administer pre- and postintervention evaluation instruments will be blind to each participant's randomly assigned treatment condition. Evaluation instruments will be administered at baseline and at three points of follow-up: one week, six months, and one year after treatment. A detailed manual describing treatment methods will be developed based on the intervention.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
New York
-
New York, New York, Stany Zjednoczone, 10029-6574
- Icahn School of Medicine at Mount Sinai
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Being at least 18years old
- Having a TBI as a result of a blow to the head followed by a loss of consciousness or period of being dazed and confused or a period of post traumatic amnesia or clinical signs of altered neurological function; this information must be medically documented (e.g., emergency medical record, hospital record, neuroradiological report, or neurological exam or record of physician's visit within 24 hours of injury)
- Being at least 6 months post injury
- Being English-speaking
- Having residential telephone service
- Living within 1.5 hours of New York City
- Having at least a sixth-grade reading level
- Meeting DSM-IV criteria for a current depressive mood disorder
- Not being in psychotherapy and being willing to abstain from seeking psychotherapy during the course of participation
- Being willing to complete questionnaires and interviews about mood, thinking skills, community participation and life satisfaction
- Agreeing to participate, verified by completion of informed consent and HIPAA documents.
- Individuals who meet criteria and are currently using prescribed mood medications will be included in the study if dosage has been stable for sixty days.
Exclusion Criteria:
- Pre-existing neurological disorder, including brain injury from an etiology other than trauma
- History of mental retardation
- Lack of capacity to sign informed consent
- Taking antidepressant medications for less than six months
- Having any changes in antidepressant medications in the last six months
- History of current or past psychosis or mania
- Current substance abuse
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Treatment Arm 1
Individual psychotherapy focused on identifying and correcting maladaptive cognitions and behaviors with the goal of improving mood.
The intervention has adapted CBT specifically to address cognitive deficits associated with TBI, which compound the cognitive distortions typical of depression.
CBT therapists embed compensatory strategies within treatment sessions to address cognitive limitations of each participant.
|
Individual psychotherapy focused on identifying and correcting maladaptive cognitions and behaviors with the goal of improving mood.
The intervention has adapted CBT specifically to address cognitive deficits associated with TBI, which compound the cognitive distortions typical of depression.
CBT therapists embed compensatory strategies within treatment sessions to address cognitive limitations of each participant.
|
Eksperymentalny: Treatment Arm 2
A client-centered individual psychotherapy treatment approach designed to address depressive disorders commonly experienced by individuals following a TBI.
In line with traditional supportive psychotherapy approaches, the objective of SPT is to improve the individual's ability to deal with problems of daily living more effectively through problem identification, praise, reassurance, encouragement, psychoeducation, advice, anticipatory guidance, and expanding awareness.
|
A client-centered individual psychotherapy treatment approach designed to address depressive disorders commonly experienced by individuals following a TBI.
In line with traditional supportive psychotherapy approaches, the objective of SPT is to improve the individual's ability to deal with problems of daily living more effectively through problem identification, praise, reassurance, encouragement, psychoeducation, advice, anticipatory guidance, and expanding awareness.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Ramy czasowe |
---|---|
Remission of depression (DSM-IV diagnosis no longer met)
Ramy czasowe: baseline
|
baseline
|
Remission of depression (DSM-IV diagnosis no longer met)
Ramy czasowe: one week after treatment completion
|
one week after treatment completion
|
Remission of depression (DSM-IV diagnosis no longer met)
Ramy czasowe: six months after treatment completion
|
six months after treatment completion
|
Remission of depression (DSM-IV diagnosis no longer met)
Ramy czasowe: one year after treatment completion
|
one year after treatment completion
|
Miary wyników drugorzędnych
Miara wyniku |
Ramy czasowe |
---|---|
Increased participation (Participation Objective, Participation Subjective)
Ramy czasowe: baseline
|
baseline
|
Improved quality of life (Life-3).
Ramy czasowe: baseline
|
baseline
|
Increased participation (Participation Objective, Participation Subjective)
Ramy czasowe: one week after treatment completion
|
one week after treatment completion
|
Increased participation (Participation Objective, Participation Subjective)
Ramy czasowe: six months after treatment completion
|
six months after treatment completion
|
Increased participation (Participation Objective, Participation Subjective)
Ramy czasowe: one year after treatment completion
|
one year after treatment completion
|
Improved quality of life (Life-3).
Ramy czasowe: one week after treatment completion
|
one week after treatment completion
|
Improved quality of life (Life-3).
Ramy czasowe: six months after treatment completion
|
six months after treatment completion
|
Improved quality of life (Life-3).
Ramy czasowe: one year after treatment completion
|
one year after treatment completion
|
Współpracownicy i badacze
Współpracownicy
Śledczy
- Główny śledczy: Wayne Gordon, Ph.D., Icahn School of Medicine at Mount Sinai
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Oszacować)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- GCO 04-0782
- H133B040033
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Cognitive behavioral therapy
-
Sarah MorrowLawson Health Research InstituteZakończony
-
Hacettepe UniversityRejestracja na zaproszenieAktywność silnika | Dysfunkcja wykonawcza | Orientacja poznawczaIndyk
-
I.R.C.C.S. Fondazione Santa LuciaCampus Bio-Medico UniversityZakończonyUderzenie | Niedowład | Paraliż kończyn górnychWłochy
-
Douglas Mental Health University InstituteRekrutacyjnySchizofrenia | Upośledzenie funkcji poznawczych | PsychozaKanada
-
Karadeniz Technical UniversityZakończonyHemodializa | Samotność | Szczęście | Dostosowanie | Terapia wspomagana przez zwierzęta | ObjawIndyk
-
ARCIM Institute Academic Research in Complementary...University Hospital TuebingenZakończony
-
Columbia UniversityZakończony
-
University of Alabama, TuscaloosaUniversity of Maryland; University of MemphisZakończony
-
Microclinic InternationalRoyal Health Awareness Society (RHAS); Jordanian Ministry of Health (MoH)ZakończonyHiperglikemia | Nadciśnienie | Otyłość | Cukrzyca typu 2 | Cukrzyca | Cukrzyca | Masy ciała | Utrata masy ciała | Ciśnienie krwi | Przybranie na wadze | Zachowanie społeczne | Waga, Ciało | Glukoza, Wysoka Krew | Styl życia, zdrowy | Zmiana masy ciała | Zachowanie, zdrowie | Redukcja ryzyka związanego ze stylem życia | Ciśnienie krwi... i inne warunkiJordania
-
NeuroTronik Inc.NieznanyOstra niewydolność sercaPanama